<DOC>
	<DOCNO>NCT00819078</DOCNO>
	<brief_summary>Bupropion use successfully safely smoke cessation adult . It also use study among adolescent population . Our hypothesis Bupropion would effective safe among adoelscent psychiatric population . A double-blind randomized controlled-trial held determine .</brief_summary>
	<brief_title>Comparative Study SR Bupropion Adolescent Smoking Cessation</brief_title>
	<detailed_description>The study conduct Geha Mental Health Center . A total 80 adolescent non-psychotic smoker recruit study . A smoker define cosumer least 5 cigarette daily . A total 80 patient recruited adolescent psychiatric ward adolescent clinic mental health center . The study group ( N=40 ) receive bupropion SR control group ( N=40 ) receive placebo medication . Age participant range 13-20 year . Both gender include ethnic origin . All participant receive detailed explanation study , aim , bupropion therapy , include possible adverse effect drug possible therapeutic alternative . They receive leaflet summarize relevant data information . Then parent sign informed consent participate study . Procedure The mental health center 's pharmacist encapsulate bupropion tablet , supply manufacturing company . The study capsule kept hospital 's pharmacy . Randomization perform use random number table . The code hold solely principal investigator , broken end study 's follow-up period , unless emergency occurs . All participant give telephone number principal investigator question problem arise . The subject group double-blindly randomize receive either bupropion placebo . The assignment group do randomly order ensure location concealment . For subject receive bupropion , dose 150 mg/d first three day , increase 150 mg twice daily , continue period eight week . In case intolerable side effect , dosage decrease 150 mg daily . On recruitment , subject screen for- - Medical history - Vital sign - Height - Weight - Place birth - Tobacco use history - Alcohol substance abuse - Elctrocardiogram ( ECG ) - Urine pregnancy test ( girl ) - Kiddie schedule affective disorder schizophrenia ( K-SADS-PL ) screen tool ( 37 ) . Possible electrocardiographic side effect bupropion report literature tachycardia conduction delay ( widened QRS complex and/or prolong QTc interval ) , none delay progress life-threatening arrhythmia , even case overdose . Exclusion criterion : - Psychiatric disorder Axis I DSM IV ( 38 ) ( control group ) - Smoking less 6 cigarette day - Using tobacco product cigarettes - Using smoke cessation treatment - Exhaled CO level le 10 ppm - Convulsive disorder history seizures - A first-degree relative convulsive disorder - Past sensitivity bupropion . - Positive pregnancy test - lactation - A lack motivation quit smoke - Alcohol substance abuse ( current alcohol withdrawal ) - Mental retardation lack ability give inform consent - Concurrent use Monoamine oxidase inhibitor ( MAO-I ) . - Anorexia nervosa bulimia nervosa . All subject evaluate weight , smoking , substance use , anxiety depressive symptom baseline , 1 month , 3 month , 6 month 1 year . Follow-up phase blind well . Evaluation time point include : - Fagerstrom Tolerance Questionnaire modify adolescent ( FTQ ( measure nicotine dependence ( 39 ) . - Quantitive information tobacco , alcohol drug use ( timeline followback method ) - Children depression inventory ( CDI ) ( 40 ) measure depression , translate validated hebrew ( 41 ) . - Children depression rating scale ( CDRS ) ( 42 ) measure depression , translate validated hebrew ( 41 ) - The Screen Child Anxiety Related Emotional Disorders ( SCARED ) measure anxiety ( 43 ; 44 ) - Exhaled air carbon monoxide ( CO ) - Urine cotinine In addiction pharmacological therapy , group study receive supportive psychoeducational treatment set group therapy . Supportive psychotherapy focus use suggestion supportive expression encourage patient goal quit smoking . Psychoeducational treatment concentrate educate patient benefit abandon smoking use informative detail regard issue . Main outcome measure : ( 1 ) Smoking cessation 3 month . ( 2 ) Decrease carve smoke .</detailed_description>
	<mesh_term>Bupropion</mesh_term>
	<criteria>adolescent ( age 1320 ) daily smoker ( 5 cigarette daily ) motivation quit nonpsychotic treated MHC Psychiatric disorder Axis I DSM IV ( 38 ) ( control group ) Smoking le 6 cigarette day Using tobacco product cigarettes Using smoke cessation treatment Exhaled CO level le 10 ppm Convulsive disorder history seizures A firstdegree relative convulsive disorder Past sensitivity bupropion . Positive pregnancy test lactation A lack motivation quit smoking Alcohol substance abuse ( current alcohol withdrawal ) Mental retardation lack ability give inform consent Concurrent use Monoamine oxidase inhibitor ( MAOI ) . Anorexia nervosa bulimia nervosa .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>20 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>adolescent</keyword>
	<keyword>bupropion</keyword>
	<keyword>smoking</keyword>
	<keyword>cessation</keyword>
	<keyword>depression</keyword>
</DOC>